SCHEMBL25752448

SCHEMBL25752448

COC(=O)c1oc2ccc(F)c(F)c2c1N

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 13/20 0.56
ALDH1A1 P00352 9/20 0.56
SMN1; SMN2 Q16637 6/20 0.56
HPGD P15428 5/20 0.56
HSD17B10 Q99714 6/20 0.52
TP53 P04637 2/20 0.52
HTT P42858 1/20 0.52
MAPK1 P28482 1/20 0.40
CELA1 Q9UNI1 1/20 0.38
AHR P35869 1/20 0.38
MAPT P10636 4/20 0.36
TSHR P16473 2/20 0.36
NPC1 O15118 4/20 0.35
RAB9A P51151 4/20 0.35
LMNA P02545 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18496528 0.82 KDM4E (0.61) KDM4EALDH1A1SMN1; SMN2HPGDHSD17B10
SCHEMBL18496523 0.75 KDM4E (0.70) KDM4EALDH1A1SMN1; SMN2HPGDHSD17B10
SCHEMBL4338832 0.73 KDM4E (0.61) KDM4EALDH1A1SMN1; SMN2HPGDHSD17B10
SCHEMBL4573629 0.72 KDM4E (1.00) KDM4EALDH1A1SMN1; SMN2HPGDHSD17B10
SCHEMBL7558755 0.70 ABL1 (0.50) KDM4EALDH1A1SMN1; SMN2HPGDHSD17B10
SCHEMBL1885241 0.70 KDM4E (1.00) KDM4EALDH1A1SMN1; SMN2HPGDHSD17B10
SCHEMBL17179762 0.69 KDM4E (0.65) KDM4EALDH1A1SMN1; SMN2HPGDHSD17B10
SCHEMBL22006944 0.69 KDM4E (0.79) KDM4EALDH1A1SMN1; SMN2HPGDHSD17B10
SCHEMBL23648008 0.68 ABL1 (0.51) KDM4EALDH1A1SMN1; SMN2HPGDHSD17B10
SCHEMBL29771218 0.68 ABL1 (0.51) KDM4EALDH1A1SMN1; SMN2HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023116390-A1 PYRIMIDINE-2(1H)-ONE-FUSED BICYCLIC COMPOUND HAVING MAT2A INHIBITORY ACTIVITY AND USE THEREOF 上海海和药物研究开发股份有限公司 2023-06-29 WO disclosed